Sarepta Therapeutics Opens New Global Headquarters In Cambridge, Mass.

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sarepta Therapeutics, Inc. (NASDAQ:SRPT), a developer of innovative RNA-based therapeutics, today announced the opening of its new global headquarters at 215 First Street in Cambridge’s Kendall Square. Sarepta executives, directors and employees will celebrate the announcement at a ribbon-cutting ceremony at 10:00 a.m. with several federal, state, and local government officials from Massachusetts, leaders of the Massachusetts life sciences and biotechnology communities, and representatives from leading Duchenne muscular dystrophy (DMD) patient advocacy groups. The new headquarters includes approximately 45,000 square feet of office and laboratory space capable of supporting early stage drug discovery and development.

Help employers find you! Check out all the jobs and post your resume.